Indivior Pharmaceuticals Inc (INDV) Cash Flow Statement

The ratio's extreme range suggests that single-quarter net income is a poor proxy for cash generation at this company. Across the full window, cumulative operating cash flow appears to track net income more closely than individual quarters indicate, which implies timing effects rather than structural earnings inflation. Investors should monitor whether the 2026 quarters, where operating cash flow of $229.0M in Q2 exceeded net income of $122.0M, reflect durable collection improvement or a temporary release of receivables.

The swing from deeply negative free cash flow in late 2025 to a strong second-quarter 2026 result suggests the business generates substantial cash when working capital is not absorbing it. The 2026Q3 margin of 23.3% still sits well above the negative readings seen in 2024Q4 through 2025Q4, which supports the view that the cash profile has improved. However, the rapid reversal implies the trend is not yet established enough to extrapolate.

The magnitude of working capital movements relative to net income indicates that receivables, inventory, and payables management is the central driver of quarterly cash results. Given that gross-to-net adjustments and specialty distribution stocking levels can shift revenue timing, the large outflows may reflect receivable build-up that reverses later. Investors should monitor whether the 2026Q1 and 2026Q3 working capital outflows of $163.0M and $36.0M mark a recurring seasonal pattern or a deterioration in collections.

Low capital intensity is consistent with a business whose manufacturing and distribution needs are largely outsourced or specialized rather than plant-heavy. Depreciation and amortization of roughly $1.0M to $8.0M per quarter sits well below capital spending in several periods, which may suggest that current capex is partly growth-oriented rather than pure maintenance. The implication is that free cash flow is more sensitive to operating and working capital dynamics than to investment decisions.

The cumulative shortfall of operating cash flow relative to reported net income over this window suggests that accrual-based earnings have run ahead of cash collection during the period. Non-cash charges such as stock-based compensation, which are small here, do not explain the gap, leaving working capital build-up as the primary candidate. This warrants further investigation into receivable aging and gross-to-net reserve movements before treating the earnings base as fully cash-backed.